Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009–2010
Tài liệu tham khảo
Clark, 2009, Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine, N Engl J Med, 361, 2424, 10.1056/NEJMoa0907650
Simonsen, 2009, Influenza vaccination and mortality benefits: new insights, new opportunities, Vaccine, 27, 6300, 10.1016/j.vaccine.2009.07.008
Savulescu, 2010, Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network—pilot case-control studies using different control groups, 2008–2009 season, Spain, Vaccine, 28, 2903, 10.1016/j.vaccine.2010.01.054
Kissling, 2009, I-MOVE towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008–9, Euro Surveill, 14, 10.2807/ese.14.44.19388-en
Valenciano, 2011, 2011 Estimates of pandemic influenza vaccine effectiveness in Europe, 2009–2010: results of influenza monitoring vaccine effectiveness in Europe (I-MOVE) multicentre case-control study, PLoS Med, 8, e1000388, 10.1371/journal.pmed.1000388
Gruppo di Lavoro INFLUNET. Istituto Superiore di Sanità. INFLUNET: sistema di sorveglianza sentinella dell‘influenza basata su medici di medicina generale e pediatri di libera scelta. Rapporto sulla stagione influenzale 2008–2009. Report No.: 10/29; 2010.
World Health Organization, 2009
Farrington, 1993, Estimation of vaccine effectiveness using the screening method, Int J Epidemiol, 22, 742, 10.1093/ije/22.4.742
Pelat, 2011, Field effectiveness of pandemic and 2009–2010 seasonal vaccines against 2009–2010 A(H1N1) influenza: estimations from surveillance data in France, PLoS ONE, 6, e19621, 10.1371/journal.pone.0019621
Cnesps-ISS, 2010